Tectonic‑1 contributes to the growth and migration of prostate cancer cells in vitro

Zhijun Wang1, Yi Gao1, Yushan Liu1

  • 1Department of Urology, Changzheng Hospital, The Second Military Medical University, Shanghai 200003, P.R. China.

Insights

The Tectonic-1 (TCTN1) gene significantly impacts prostate cancer cell growth. Silencing TCTN1 reduces cancer cell viability, proliferation, and migration, suggesting its potential as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Tectonic-1 (TCTN1) is an embryonic development gene.
  • Prostate cancer remains a significant health concern with ongoing research into its genetic drivers.
  • Understanding novel gene functions in cancer progression is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the role of the Tectonic-1 (TCTN1) gene in prostate cancer cell viability and migration.
  • To determine the effect of TCTN1 gene silencing on prostate cancer cell behavior in vitro.
  • To explore TCTN1 as a potential therapeutic target or biomarker for prostate cancer.

Main Methods:

  • Constructed lentivirus-mediated short hairpin RNA (shRNA) to silence TCTN1 expression.
  • Utilized PC-3 and DU145 human prostate cancer cell lines.
  • Assessed cell viability (MTT assay), proliferation (colony formation assay), cell cycle distribution (flow cytometry), and migration (Transwell assay).

Main Results:

  • TCTN1 was found to be widely expressed in human prostate cancer cell lines.
  • Knockdown of TCTN1 significantly suppressed cell viability and colony formation in PC-3 and DU145 cells.
  • TCTN1 silencing led to cell cycle arrest and inhibited cell migration in both cell lines.

Conclusions:

  • The Tectonic-1 (TCTN1) gene plays a direct role in promoting prostate cancer cell growth and migration in vitro.
  • TCTN1 is a potential novel biomarker for early prostate cancer detection.
  • TCTN1 warrants further investigation for its potential in developing new gene therapies for prostate cancer.